Reuters logo
BRIEF-Seqirus receives FDA nod for flu vaccine for ages four and above
May 24, 2016 / 1:01 AM / 2 years ago

BRIEF-Seqirus receives FDA nod for flu vaccine for ages four and above

May 23 (Reuters) - Seqirus

* Flucelvax Quadrivalent will be available during 2016-2017 flu season

* Seqirus receives FDA approval for Flucelvax Quadrivalent(influenza vaccine) for people four years of age and older Source text for Eikon: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below